Dose escalation decisions should always be made by your prescribing healthcare provider based on your individual progress, tolerability, and health status
In a study where IGFBP-3 appeared to act as a tumor suppressor, miR-21, which is oncogenic and highly expressed in GBM tissue, was shown to downregulate IGFBP-3 [52]
OTA is absorbed passively throughout the gastrointestinal tract and actively in the kidneys
If youre considering GLP-1 therapy, its important to understand how these medications work, how they may affect muscle composition, and how a comprehensive plan can help preserve strength and function
Pairing or supplementing B12 is sometimes framed as a safeguard against gaps that can open up during active weight loss
Carmen Scheibenbogen, former ME Research UK-funded researcher, discussed whether GLP-1 receptor agonists could have potential in the future management of ME/CFS